Syantra DX Breast Cancer is a precision medicine test based on a whole blood liquid biopsy, machine learning derived algorithms for processing data and a multi-biomarker, gene expression signature for breast cancer. It measures a panel of gene expression biomarkers from whole blood. It then uses a software package, developed with machine learning, to interpret data. It provides a molecular approach to breast cancer screening that can detect invasive disease at early stages.